Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...

Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics ...